Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zoetis (ZTS), Enovis (ENOV) and Icon (ICLR)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zoetis (ZTS – Research Report), Enovis (ENOV – Research Report) and Icon (ICLR – Research Report).
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Zoetis (ZTS)
Stifel Nicolaus analyst Jonathan Block maintained a Hold rating on Zoetis yesterday and set a price target of $130.00. The company’s shares closed last Friday at $125.92.
According to TipRanks.com, Block is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Zoetis with a $154.00 average price target.
See today’s best-performing stocks on TipRanks >>
Enovis (ENOV)
UBS analyst Danielle Antalffy maintained a Buy rating on Enovis today and set a price target of $50.00. The company’s shares closed last Friday at $26.51.
According to TipRanks.com, Antalffy is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Enovis with a $46.43 average price target.
Icon (ICLR)
In a report issued on January 2, Patrick B Donnelly from Citi maintained a Hold rating on Icon, with a price target of $200.00. The company’s shares closed last Friday at $188.67, close to its 52-week low of $174.93.
According to TipRanks.com, Donnelly is a 4-star analyst with an average return of
Currently, the analyst consensus on Icon is a Moderate Buy with an average price target of $199.70.
